Dishman Carbogen AmicsNSE:DCAL -2.41%71 ROA % is 0.73% as of Mar. 2026, which is 33% above its 10-year median of 0.55. GuruFocus rates NSE:DCAL with a GF Score™ of 71/100 and a GF Value™ of ₹236.74 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 1,422 Biotechnology companies, Dishman Carbogen Amics ranks better than 82% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Dishman Carbogen Amics's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹870 Mil.
Dishman Carbogen Amics's average Total Assets over the quarter that ended in Mar. 2026 was ₹119,233 Mil. Therefore, Dishman Carbogen Amics's annualized ROA % for the quarter that ended in Mar. 2026 was 0.73%.
The historical rank and industry rank for Dishman Carbogen Amics's ROA % or its related term are showing as below:
NSE:DCAL'
s ROA % Range Over the Past 10 Years
Min: -1.99 Med: 0.55 Max: 3.04
Current: 0.89
During the past 13 years, Dishman Carbogen Amics's highest ROA % was 3.04%. The lowest was -1.99%. And the median was 0.55%.
NSE:DCAL's ROA % is ranked better than 82% of 1422
companies
in the Biotechnology industry
Industry Median: -32.87
vs NSE:DCAL: 0.89
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Dishman Carbogen Amics's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dishman Carbogen Amics ROA % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Dishman Carbogen Amics's ROA % distribution charts can be found below:
* The bar in red indicates where Dishman Carbogen Amics's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Dishman Carbogen Amics (NSE:DCAL) has a ROA % of 0.73% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Dishman Carbogen Amics and its competitors. This is 33% above median its historical median of 0.55. According to the industry distribution chart, Dishman Carbogen Amics ranks #256 out of 1422 companies in the Biotechnology industry, placing it in the top 18%.
Is Dishman Carbogen Amics' ROA % too high?
Dishman Carbogen Amics' current ROA % of 0.73% is 33% above median its 10-year median of 0.55. Based on the distribution chart, Dishman Carbogen Amics ranks #256 out of 1422 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Dishman Carbogen Amics has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dishman Carbogen Amics' ROA % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Dishman Carbogen Amics ranks #256 out of 1422 companies for ROA %. This places Dishman Carbogen Amics in the top 18% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Biotechnology company?
A good ROA % depends on the Biotechnology industry context. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Dishman Carbogen Amics and its competitors. Dishman Carbogen Amics's current ROA % is 0.73%, which is 33% above median its own 10-year median of 0.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dishman Carbogen Amics stock overvalued right now?
Based on GuruFocus' analysis, Dishman Carbogen Amics (NSE:DCAL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹236.74, compared to a current price of ₹170.02 — trading 28.2% below its estimated fair value. The current ROA % is 0.73%, which is 33% above median its 10-year median of 0.55. Dishman Carbogen Amics' overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Dishman Carbogen Amics (NSE:DCAL), the current ROA % is 0.73% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dishman Carbogen Amics (NSE:DCAL) Overvalued in 2026?
Based on GuruFocus' analysis, Dishman Carbogen Amics stock appears to be undervalued.
The current stock price of ₹170.02 is trading 28.2% below its estimated GF Value™ of ₹236.74.
GuruFocus considers Dishman Carbogen Amics to be Modestly Undervalued.
Key valuation signals for NSE:DCAL:
ROA %: 0.73% (33% above median its 10-year median of 0.55)
GF Value™: ₹236.74 vs. price of ₹170.02 (28.2% below fair value)
No single metric tells the full story. See the NSE:DCAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dishman Carbogen Amics Ltd is a biotechnology company that provides contract research and manufacturing services for pharmaceutical companies. It manufactures bulk drugs, specialty chemicals, and outsourced goods. Additionally, the company produces vitamins, such as vitamin D2 and vitamin D3, reagents, antiseptics and disinfectants, transfer catalysts, personal-care ingredients, pharma intermediates, and ammonium and phosphonium high-purity solid Quats. The business generates the vast majority of its revenue in India.
71GF Score
Get the complete analysis for NSE:DCAL
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:DCAL has been successfully added to your 
